(Q48210303)

English

Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer. (English)

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Crispin J. Miller

15

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Fiona Blackhall

17

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

object named as

Louise Carter

1

0 references

object named as

Caroline Dive

18

0 references

author name string

Dominic G Rothwell

2

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Barbara Mesquita

3

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Christopher Smowton

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Hui Sun Leong

5

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Fabiola Fernandez-Gutierrez

6

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Yaoyong Li

7

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Deborah J Burt

8

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Jenny Antonello

9

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Christopher J Morrow

10

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Cassandra L Hodgkinson

11

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Karen Morris

12

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Lynsey Priest

13

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Mathew Carter

14

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Andrew Hughes

16

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Ged Brady

19

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

language of work or name

0 references

publication date

21 November 2016

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Nature Medicine

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

23

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

1

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

114-119

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

https://scigraph.springernature.com/pub.10.1038/nm.4239

0 references

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Comprehensive genomic profiles of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Mutational heterogeneity in cancer and the search for new cancer-associated genes

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Origins, genetic landscape, and emerging therapies of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Clinical correlation of extensive-stage small-cell lung cancer genomics.

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Circulating tumor cell as a diagnostic marker in primary lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Molecular profiling of single circulating tumor cells with diagnostic intention

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Small cell lung cancer: have we made any progress over the last 25 years?

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

X:Map: annotation and visualization of genome structure for Affymetrix exon array analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

21 January 2018

Small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

7 January 2021

based on heuristic

inferred from DOI database lookup

Building Predictive Models inRUsing thecaretPackage

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

7 January 2021

based on heuristic

inferred from DOI database lookup

RStudio: A Platform-Independent IDE for R and Sweave

1 reference

https://api.crossref.org/works/10.1038%2FNM.4239

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NM.4239

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/27869802

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48210303&oldid=1459032366"